Neovasc Inc. (TSE:NVCN – Get Free Report) shares rose 0.6% on Monday . The stock traded as high as C$40.15 and last traded at C$40.15. Approximately 399 shares traded hands during trading, a decline of 81% from the average daily volume of 2,123 shares. The stock had previously closed at C$39.92.
Neovasc Stock Performance
The stock has a market capitalization of C$110.81 million, a price-to-earnings ratio of -1.96 and a beta of 2.01. The company has a current ratio of 8.44, a quick ratio of 8.04 and a debt-to-equity ratio of 44.86. The business’s 50-day simple moving average is C$40.15.
Neovasc Company Profile
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
Read More
- Five stocks we like better than Neovasc
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Investing In Automotive Stocks
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
